Stacey Douglas
About Stacey Douglas
Stacey Douglas serves as the Regional Medical Affairs Director for the Southeast at Mirati Therapeutics, where she focuses on advancing treatments for KRAS mutations. With over 25 years of experience in oncology and advanced degrees in Nursing Administration and Nursing, she is dedicated to providing hope to cancer patients through innovative medical solutions.
Work at Mirati Therapeutics
Stacey Douglas serves as the Regional Medical Affairs Director for the Southeast at Mirati Therapeutics. She has held this position since 2020, contributing to the company's mission of advancing innovative therapies for cancer patients. In her role, she focuses on the development and implementation of medical strategies that support the company's portfolio, particularly in the area of KRAS mutations, which are significant in cancer treatment.
Education and Expertise
Stacey Douglas holds a Bachelor of Science in Nursing Administration from Ohio Wesleyan University and a Master of Science in Nursing from Vanderbilt University. Her educational background equips her with a strong foundation in nursing and healthcare management. With over 25 years of experience in oncology, she possesses specialized knowledge in drug development for previously undruggable targets, enhancing her expertise in cancer therapy.
Background
Stacey Douglas has a significant professional history in the field of oncology. Before joining Mirati Therapeutics, she worked at Genentech as a Senior Medical Science Liaison for 17 years. During her tenure at Genentech, she developed a deep understanding of cancer therapies and contributed to various initiatives aimed at improving patient outcomes in oncology.
Achievements
Throughout her career, Stacey Douglas has focused on providing hope to cancer patients through innovative medical solutions. Her work in advancing treatments for KRAS mutations highlights her commitment to addressing challenging areas in cancer research. Her extensive experience and expertise have positioned her as a key contributor to the field of oncology.